Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 5/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KHK | P50053 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.36 |
| ▸ | SUV39H2 | Q9H5I1 | 1/20 | 0.36 |
| ▸ | QDPR | P09417 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16554303 | 0.76 | JAK2 (0.50) | HTR2CSIGMAR1KDM4EALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL16553729 | 0.76 | JAK2 (0.50) | HTR2CSIGMAR1KDM4EALDH1A1MAPT | |
| SCHEMBL24377330 | 0.76 | HTR2C (0.44) | HTR2CSIGMAR1HTR6KDM4EALDH1A1 | |
| SCHEMBL21077874 | 0.71 | JAK1 (0.48) | HTR2CSIGMAR1HTR6KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL2078358 | 0.69 | HTR2C (0.61) | HTR2CSIGMAR1HTR6HTR1AHTR7 | |
| SCHEMBL3434585 | 0.69 | HTR2C (0.61) | HTR2CSIGMAR1HTR6HTR1AHTR7 | |
| SCHEMBL16565643 | 0.68 | HTR2C (0.47) | HTR2CSIGMAR1HTR6HTR1AHTR7 | |
| SCHEMBL18278895 | 0.67 | HTR2C (0.50) | HTR2CSIGMAR1HTR6KDM4EALDH1A1 | |
| SCHEMBL29462225 | 0.66 | HTR2C (0.45) | HTR2CSIGMAR1HTR6KDM4EALDH1A1 | |
| SCHEMBL20508198 | 0.66 | SIGMAR1 (0.46) | HTR2CSIGMAR1KDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190666-A1 | Heteroaryl Compounds as PIKK Inhibitors | AMGEN INC. (US) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190666-A1 | Heteroaryl Compounds as PIKK Inhibitors | PIK3CA, PIKFYVE, PIK3CD | HTR2C 4282/4885SIGMAR1 3195/4885HTR6 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.